Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis

Abstract

There is very little evidence regarding the safety and efficacy of opioids for the control of dyspnoea in the terminal stages of idiopathic pulmonary fibrosis (IPF). We conducted an open case series study of 11 elderly opioid-naive patients referred for management of severe breathlessness before and after their first injection of 2.5 mg diamorphine subcutaneously. Subjective breathlessness, measured by a 100 mm visual analogue scale, fell by a mean of 47 mm in the first 15 min (PB 0.0001) and the mean heart rate fell by 12/min (P-0.007). There were small non-significant falls in the mean respiratory rate (2/min), systolic blood pressure (6 mmHg) and oxygen saturation (1%). These changes were maintained at 30 min. Follow up treatment with oral morphine remained effective in reducing the symptom of breathlessness and no patient showed signs of respiratory depression. Low dose opioids are effective and safe in the palliative management of IPF in frail elderly patients.

Keywords

diamorphine idiopathic pulmonary fibrosis dyspnoea elderly

Get full access to this article

View all access options for this article.

References

Araki T , Katsura H , Sawabe M et al. A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients . Intern Med 2003; 42: 483–489 .

Webb M , Moody LE , Mason LA . Dyspnoea assessment and management in hospice patients with pulmonary disorders . Am J Hosp Palliat Care 2000; 17: 259–264 .

Higginson I , McCarthy M . Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J Roy Soc Med 1989; 82: 264–267 .

O'Driscoll M , Corner J , Bailey C . The experience of breathlessness in lung cancer . Eur J Cancer Care (Engl) 1999; 8: 37–43 .

Ripamonti C . Management of dyspnoea in advanced cancer patients . Support Cancer Care 1999; 7: 233–243 .

Harris-Eze A , Sridhar G , Clemens RE et al. Low-dose nebulized morphine does not improve exercise in interstitial lung disease . Am J Respir Crit Care Med 1995; 152: 1940–1945 .

Brack T , Jubran A , Tobin MJ . Dyspnoea and decreased variability of breathing in patients with restrictive lung disease . Am J Respir Crit Care Med 2002; 165: 1260–1264 .

Muers MF . Opioids for dyspnoea . Thorax 2002; 57: 922–923 .

Jennings A-L , Davies AN , Higgins JPT et al. A systematic review of the use of opioids in the management of dyspnoea . Thorax 2002; 57: 939–944 .

10.

Abernethy AP , Currow DC , Frith P et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea . Brit Med J 2003; 327: 523–526 .

11.

Jennings AL , Davies AN , Higgins JP , Broadley K . Opioids for the palliation of breathlessness in terminal illness . Cochrane Database Syst Rev 2001; 4: CD002066.